Saturday 17 October 2026 Export BNGO’s income statement to Excel — free account

Bionano Genomics, Inc.

BNGO Healthcare Medical Instruments & Supplies

Bionano Genomics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $28.5 million, down 7.37% from fiscal 2024. In the quarter to June 2026, revenue grew 21.4%, EPS grew 67.8%, free cash flow fell 33.9% and total debt fell 1.91%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

1.25 0.12 −8.76%

Follow BNGO

Alert me

Market cap: $16.1M
P/E: 0.0×
Fwd P/E: −0.6×
Dividend yield: —
F-score: 5/9
Altman Z: −14.26
Beneish M: −3.39
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	0.00	0.00	0.00	0.00	+8 more quarters Free account
P/S ratio Full definition →	0.43	0.45	0.29	0.32
P/FCF ratio Full definition →	0.00	0.00	0.00	0.00
P/Operating CF Full definition →	(2.79)	(2.25)	(2.00)	(1.54)
P/B ratio Full definition →	0.41	0.34	0.19	0.18
Price to Tangible BV Full definition →	0.44	0.37	0.21	0.21
EV/Sales Full definition →	0.67	0.20	(0.12)	(0.17)
EV/EBITDA Full definition →	0.00	0.00	0.14	0.18
EV/Operating CF Full definition →	(0.99)	(0.30)	0.21	0.27
EV/FCF Full definition →	(0.99)	(0.30)	0.21	0.27
Quick Ratio Full definition →	1.47	1.36	1.51	1.58
Current Ratio Full definition →	2.48	1.84	1.98	2.12
Net Debt/EBITDA Full definition →	1.40	3.70	4.07	4.47
Debt/Assets Full definition →	7.24%	5.34%	4.73%	4.42%
Debt/Equity Full definition →	0.11	0.09	0.08	0.07
Asset Turnover Full definition →	0.49	0.40	0.38	0.35
Operating CF/Net income Full definition →	0.63	0.69	0.53	0.70
Capex/Depreciation Full definition →	0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →	36.57%	46.94%	40.61%	38.60%
Selling, General and Administrative Expense of Revenue Full definition →	104.56%	119.78%	109.51%	123.04%
Intangible Assets out of Total Assets Full definition →	0.04	0.05	0.06	0.07
Share Based Compensation of Revenue Full definition →	11.87%	10.02%	11.65%	12.77%
Graham Net Nets Full definition →	0.68	0.91	1.95	2.14
Graham Number Full definition →	0.00	0.00	0.00	0.00
Earnings Yield Full definition →	(267.26%)	(373.50%)	(311.11%)	(689.32%)
Free Cash Flow Yield Full definition →	(157.76%)	(151.03%)	(197.43%)	(205.71%)
Revenue per Share Full definition →	0.71	0.61	1.46	1.38
Operating CF per Share Full definition →	(0.40)	(0.52)	(0.77)	(1.11)
Capex per Share Full definition →	0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →	(0.40)	(0.52)	(0.77)	(1.11)
Cash per Share Full definition →	0.90	2.25	5.42	5.97
Shareholders Equity per Share Full definition →	2.74	3.41	8.16	9.33
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	2.74	3.41	8.16	9.33
Free Cash Flow Full definition →	(4.67)	(5.72)	(4.17)	(5.92)
Working Capital Full definition →	14.84	17.75	22.44	25.82
Net Current Asset Value Full definition →	8.89	11.63	16.23	19.54
EV/EBIT Full definition →	0.00	0.00	0.10	0.14
Capex to Sales Full definition →	0.00	0.00	0.00	0.00
Price to Operating Income Full definition →	0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →	3.93	3.74	4.98	4.92
Average Payables Full definition →	5.40	5.81	6.28	7.35
Average Inventory Full definition →	6.92	7.43	8.28	10.69
Average Assets Full definition →	61.80	71.61	75.13	83.21
Average Common Equity Full definition →	38.49	42.83	39.90	49.33

Fold the line items

Columns are period end dates

Stockrow Weekly